RHYTHM PHARMACEUTICALS

rhythm-pharmaceuticals-logo

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. Their lead peptide product candidate, setmelanotide, is a potent, first-in-class melanocortin-4 receptor (MC4R) agonist for the treatment of rare genetic disorders of obesity. They believe that setmelanotide, for which they have exclusive worldwide rights, has the potential to serve as replacement therapy for the treatment of melanocortin 4, or MC4, pathway deficiencies. The MC4 pathway is a compelling target for treating these genetic disorders because of its critical role in regulating appetite and weight, and peptide therapeutics are uniquely suited to activating this target.
#People #Financial #Event #Website #More

RHYTHM PHARMACEUTICALS

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2010-02-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.rhythmtx.com

Total Employee:
101+

Status:
Active

Total Funding:
637.7 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics



Current Advisors List

elizabeth-stoner_image

Elizabeth Stoner Senior Clinical Advisor @ Rhythm Pharmaceuticals
Advisor
2010-01-01

steven-peter_image

Steven Peter Board Member @ Rhythm Pharmaceuticals
Board_member

ed-mathers_image

Ed Mathers Board Member @ Rhythm Pharmaceuticals
Board_member

Current Employees Featured

david-connolly_image

David Connolly
David Connolly Head of Investor Relations and Corporate Communications @ Rhythm Pharmaceuticals
Head of Investor Relations and Corporate Communications
2019-05-01

michelle-hylan_image

Michelle Hylan
Michelle Hylan Clinical Consultant @ Rhythm Pharmaceuticals
Clinical Consultant
2014-06-01

hunter-smith_image

Hunter Smith
Hunter Smith Chief Financial Officer @ Rhythm Pharmaceuticals
Chief Financial Officer

pamela-cramer_image

Pamela Cramer
Pamela Cramer Chief Human Resources Officer @ Rhythm Pharmaceuticals
Chief Human Resources Officer

joe-shulman_image

Joe Shulman
Joe Shulman Chief Technical Officer @ Rhythm Pharmaceuticals
Chief Technical Officer
2022-02-01

linda-shapiro-manning_image

Linda Shapiro Manning
Linda Shapiro Manning Chief Medical Officer (CMO) @ Rhythm Pharmaceuticals
Chief Medical Officer (CMO)
2021-09-10

irene-aquino_image

Irene Aquino
Irene Aquino Vice President, Patient Advocacy and Customer Engagement @ Rhythm Pharmaceuticals
Vice President, Patient Advocacy and Customer Engagement
2021-02-01

jennifer-chien_image

Jennifer Chien
Jennifer Chien Executive Vice President, Head of North America @ Rhythm Pharmaceuticals
Executive Vice President, Head of North America
2020-11-01

patrick-kleyn_image

Patrick Kleyn
Patrick Kleyn SVP and Head of Translational Research and Development @ Rhythm Pharmaceuticals
SVP and Head of Translational Research and Development
2022-02-01

lex-ht-van-der-ploeg_image

Lex H.T. Van der Ploeg
Lex H.T. Van der Ploeg Consultant @ Rhythm Pharmaceuticals
Consultant
2019-07-01

Founder


bart-henderson_image

Bart Henderson

elizabeth-stoner_image

Elizabeth Stoner

Stock Details


Company's stock symbol is NASDAQ:RYTM

Investors List

healthcare-royalty-partners_image

HealthCare Royalty Partners

HealthCare Royalty Partners investment in Post-IPO Debt - Rhythm Pharmaceuticals

ipsen_image

Ipsen

Ipsen investment in Venture Round - Rhythm Pharmaceuticals

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Venture Round - Rhythm Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Venture Round - Rhythm Pharmaceuticals

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Rhythm Pharmaceuticals

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Venture Round - Rhythm Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Venture Round - Rhythm Pharmaceuticals

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Venture Round - Rhythm Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series A - Rhythm Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series A - Rhythm Pharmaceuticals

Official Site Inspections

http://www.rhythmtx.com Semrush global rank: 1.77 M Semrush visits lastest month: 13.17 K

  • Host name: 141.193.213.21
  • IP address: 141.193.213.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Rhythm Pharmaceuticals" on Search Engine

dfkcompany.com © 2022. All rights reserved